Hematologic Malignancies
Showing NaN - NaN of 27
Solid Tumor, Hematologic Malignancies Trial in United States (LGX818)
Terminated
- Solid Tumor
- Hematologic Malignancies
-
Birmingham, Alabama
- +12 more
Mar 1, 2021
Hematologic Malignancies Trial in United States (IPI-145 (duvelisib))
Terminated
- Hematologic Malignancies
- IPI-145 (duvelisib)
-
New York, New York
- +3 more
Mar 15, 2021
Hematologic Malignancies Trial in Houston (BPX-501, AP1903)
Withdrawn
- Hematologic Malignancies
- BPX-501
- AP1903
-
Houston, TexasMD Anderson Cancer Center
Oct 1, 2020
Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies Trial in Houston (Cyclophosphamide, Fludarabine,
Completed
- Blood Stem Cell Transplant Failure
- +2 more
- Cyclophosphamide
- +9 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Mar 12, 2020
Cancer, Hematologic Malignancies Trial in Houston (TAPA-pulsed DC vaccine)
Withdrawn
- Cancer
- Hematologic Malignancies
- TAPA-pulsed DC vaccine
-
Houston, TexasMD Anderson Cancer Center
Oct 10, 2019
Solid Tumor, Hematologic Malignancies Trial in United States (BGJ398)
Terminated
- Solid Tumor
- Hematologic Malignancies
-
Birmingham, Alabama
- +55 more
May 28, 2019
Hematologic Malignancies Trial in Houston (Tezacitabine (FMdC))
Completed
- Hematologic Malignancies
- Tezacitabine (FMdC)
-
Houston, TexasUT MD Anderson Cancer Center
Oct 31, 2018
Chronic Myelogenous Leukemia, Hematologic Malignancies Trial in United States (Ponatinib)
Completed
- Chronic Myelogenous Leukemia
- Hematologic Malignancies
-
San Francisco, California
- +4 more
May 15, 2018
Cancer, Hematologic Malignancies, Leukemia Trial in Stony Brook, Cleveland, Houston (Arm 1- Dose Escalation, Arm 2- Dose
Completed
- Cancer
- +3 more
- Arm 1- Dose Escalation
- Arm 2- Dose Expansion
-
Stony Brook, New York
- +2 more
Nov 1, 2017
Hematologic Malignancies Trial in Houston (biological, drug, procedure, radiation)
Terminated
- Hematologic Malignancies
- Campath 1H
- +4 more
-
Houston, Texas
- +1 more
Sep 20, 2016
Invasive Fungal Infections, Hematologic Malignancies Trial in Houston (Posaconazole, ABLC)
Completed
- Invasive Fungal Infections
- Hematologic Malignancies
-
Houston, TexasUT MD Anderson Cancer Center
Aug 22, 2016
Advanced Solid Tumors, Hematologic Malignancies Trial in United States (IXAZOMIB)
Completed
- Advanced Solid Tumors
- Hematologic Malignancies
-
Fairway, Kansas
- +3 more
May 3, 2016
Hematologic Malignancies Trial in Houston (Cloretazine, Fludarabine)
Completed
- Hematologic Malignancies
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012